figshare
Browse
Supplementrary Tables.docx (36.73 kB)

Supplementary Tables. Meta-analyses of deflazacort versus prednisone/prednisolone in patients with nonsense mutation Duchenne muscular dystrophy.

Download (36.73 kB)
dataset
posted on 2021-10-25, 10:30 authored by Perry B Shieh, Gary Elfring, Panayiota Trifillis, Claudio Santos, Stuart W Peltz, Julie A Parsons, Susan Apkon, Basil T Darras, Craig Campbell, Craig M McDonald
Supplementary Table 1. Search strategy for Ovid MEDLINE® (1 January 2000 to 30 November 2020).

Supplementary Table 2. Search strategy for Ovid EMBASE® (1 January 2000 to 30 November 2020).

Supplementary Table 3. Primary and post-hoc studies of patients receiving deflazacort or prednisone/prednisolone.

Funding

This research was funded by PTC Therapeutics, Inc., and did not receive any specific grant from funding agencies in the public, commercial or not-for-profit sectors.

History

Usage metrics

    Journal of Comparative Effectiveness Research

    Categories

    Keywords

    deflazacortDuchenne muscular dystrophymeta-analysisnonsense mutation Duchenne muscular dystrophyprednisoneprednisoloneNeurology and Neuromuscular Diseases

    Licence

    CC BY-NC-ND 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC